|
| 37775020 | Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation. | Pharmacol Res | 2023 |
| 34486071 | Two experts and a newbie: [<sup>18</sup>F]PARPi vs [<sup>18</sup>F]FTT vs [<sup>18</sup>F]FPyPARP-a comparison of PARP imaging agents. | Eur J Nucl Med Mol Imaging | 2022 |
| 35806468 | Hepatic Expression of the Na<sup>+</sup>-Taurocholate Cotransporting Polypeptide Is Independent from Genetic Variation. | Int J Mol Sci | 2022 |
| 35995278 | Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation. | Pharmacol Ther | 2022 |
| 33455503 | Differential <i>in vitro</i> interactions of the Janus kinase inhibitor ruxolitinib with human SLC drug transporters. | Xenobiotica | 2021 |
| 33495337 | Targeting OCT3 attenuates doxorubicin-induced cardiac injury. | Proc Natl Acad Sci U S A | 2021 |
| 33674913 | Genetic and Epigenetic Regulation of Organic Cation Transporters. | Handb Exp Pharmacol | 2021 |
| 33802215 | Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters. | Pharmaceutics | 2021 |
| 33523504 | Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors. | Fundam Clin Pharmacol | 2021 |
| 34025422 | Effects of a Common Eight Base Pairs Duplication at the Exon 7-Intron 7 Junction on Splicing, Expression, and Function of OCT1. | Front Pharmacol | 2021 |
| 33434947 | Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins. | Br J Pharmacol | 2021 |
| 31350763 | Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1. | Clin Pharmacol Ther | 2020 |
| 31834804 | Clinically Relevant OATP2B1 Inhibitors in Marketed Drug Space. | Mol Pharm | 2020 |
| 33013684 | The Membrane Transporter OAT7 (SLC22A9) Is Not a Susceptibility Factor for Osteoporosis in Europeans. | Front Endocrinol (Lausanne) | 2020 |
| 32867487 | Direct Automated MALDI Mass Spectrometry Analysis of Cellular Transporter Function: Inhibition of OATP2B1 Uptake by 294 Drugs. | Anal Chem | 2020 |
| 32308125 | Pharmacoresponse in genetic generalized epilepsy: a genome-wide association study. | Pharmacogenomics | 2020 |
| 32141622 | Testing association of rare genetic variants with resistance to three common antiseizure medications. | Epilepsia | 2020 |
| 30189235 | Inhibition of organic cation transporter (OCT) activities by carcinogenic heterocyclic aromatic amines. | Toxicol In Vitro | 2019 |
| 29059457 | Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia. | Hepatology | 2018 |
| 29944835 | Cellular Uptake of the Atypical Antipsychotic Clozapine Is a Carrier-Mediated Process. | Mol Pharm | 2018 |
| 29890226 | The fruit fly Drosophila melanogaster as an innovative preclinical ADME model for solute carrier membrane transporters, with consequences for pharmacology and drug therapy. | Drug Discov Today | 2018 |
| 30070687 | Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma. | Int J Cancer | 2018 |
| 28539468 | Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin". | Sci Transl Med | 2017 |
| 28140687 | The importance of drug transporter characterization to precision medicine. | Expert Opin Drug Metab Toxicol | 2017 |
| 28209616 | OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues. | Cancer Res | 2017 |
| 25896536 | Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant. | Pharmacogenomics J | 2016 |
| 26410689 | Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics. | Clin Pharmacokinet | 2016 |
| 27659854 | Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors. | Trends Pharmacol Sci | 2016 |
| 27165417 | Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine. | Arch Toxicol | 2016 |
| 27435027 | Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes. | Sci Rep | 2016 |
| 26979622 | A phosphotyrosine switch regulates organic cation transporters. | Nat Commun | 2016 |
| 26239079 | Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors. | Pharmacogenomics J | 2016 |
| 25418285 | Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here? | J Intern Med | 2015 |
| 26384346 | MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma. | Oncotarget | 2015 |
| 25860377 | Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature. | Clin Pharmacokinet | 2015 |
| 25640272 | Role of ABC transporters in fluoropyrimidine-based chemotherapy response. | Adv Cancer Res | 2015 |
| 24397389 | Solute carrier transporter and drug-related nephrotoxicity: the impact of proximal tubule cell models for preclinical research. | Expert Opin Drug Metab Toxicol | 2014 |
| 25231932 | Differential expression of drug uptake and efflux transporters in Japanese patients with hepatocellular carcinoma. | Drug Metab Dispos | 2014 |
| 24566939 | Genetic biomarkers in epilepsy. | Neurotherapeutics | 2014 |
| 24352644 | Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1). | Clin Cancer Res | 2014 |
| 23277337 | Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects. | Trends Pharmacol Sci | 2013 |
| 23881922 | DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome. | Clin Cancer Res | 2013 |
| 23709238 | Histamine transport and metabolism are deranged in salivary glands in Sjogren's syndrome. | Rheumatology (Oxford) | 2013 |
| 23311897 | Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1. | Genome Med | 2013 |
| 22457399 | Organic anion transporters and their implications in pharmacotherapy. | Pharmacol Rev | 2012 |
| 22970772 | Multidrug and toxin extrusion proteins as transporters of antimicrobial drugs. | Expert Opin Drug Metab Toxicol | 2012 |
| 22783830 | Retigabine/Ezogabine, a KCNQ/K(V)7 channel opener: pharmacological and clinical data. | Expert Opin Pharmacother | 2012 |
| 22453193 | Human pregnane X receptor genotype of the donor but not of the recipient is a risk factor for delayed graft function after renal transplantation. | Clin Pharmacol Ther | 2012 |
| 21103969 | Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. | Handb Exp Pharmacol | 2011 |
| 22196450 | DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma. | Genome Med | 2011 |